Lead sponsor
University of Wisconsin, Madison
6 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
6
Trials led
0
Ongoing
283
Total enrollment
5
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
3
Phase 2/3
2
Phase 4
1
Trials by status
Completed
6
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's DiseaseAge 55-90Ph 2/3Completed20